Cbd Expression Genetics

CBD Expression Genetics refers to the inherited pathways controlling cannabidiol (CBD) production in cannabis plants, distinct from THC-dominant pathways. These genetics are polygenic, meaning multiple genes influence CBD levels, and expression can vary based on both genotype and environmental factors. Breeders working in this category often reference chemotype classification systems—particularly Type III (CBD-dominant) and Type II (balanced CBD/THC) strains—which emerged from research into hemp and high-CBD cultivars. Lineage records frequently report that CBD expression depends partly on recessive alleles at the THCA synthase locus, though other regulatory genes also contribute to final cannabinoid ratios. Understanding CBD expression genetics is foundational for developing stable, repeatable high-CBD lines suitable for both breeding programs and cultivation.

Breeders use CBD expression genetics to create stable chemotypes with predictable cannabinoid profiles, enabling crosses that maintain high CBD while minimizing THC variability. Knowledge of CBD inheritance patterns helps selectors identify and fix desired phenotypes across generations, essential for regulatory compliance and therapeutic-use breeding goals.